Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation

    Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation

    FromThe Drill Down

    Start listeningView podcast show

    Ep. 122: Tesla accounting, Adaptive Biotech’s cancer blood test, IBM and AutoNation

    FromThe Drill Down

    ratings:
    Length:
    48 minutes
    Released:
    Oct 21, 2021
    Format:
    Podcast episode

    Description

    A blood test for cancer? Adaptive Biotech founders Chad and Harlan Robins explain. (Yes, they’re brothers!) (ADPT)  Tesla’s novel accounting treatment for non-existent Full Self Driving Cars (TSLA). AutoNation says car shortages will persist through 2023 (AN). The Incredible Shrinking IBM. The Drill Down with Cory Johnson offers a daily look at the business stories behind stocks on the move.
    Learn more about your ad choices. Visit megaphone.fm/adchoices
    Released:
    Oct 21, 2021
    Format:
    Podcast episode

    Titles in the series (100)

    The Drill Down is a daily podcast focused on business fundamentals of the biggest stock movers of the market day, hosted by veteran financial journalist Cory Johnson. Through insightful interviews with CEOs and investors, meaningful research and in-depth analysis, The Drill Down provides a clearer picture of what’s really going on under the hood at publicly traded companies. This is business news for business people.